[Cost-Consequence Analysis of Vedolizumab Initiation Timing Strategies in Crohn’s Disease in Italy]. (2026). Farmeconomia. Health Economics and Therapeutic Pathways, 27(1). https://doi.org/10.7175/fe.v27i1.1605